Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,443 INR | -1.21% | +1.98% | +0.74% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- The company has insufficient levels of profitability.
- With an expected P/E ratio at 74.95 and 67.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.74% | 17.33B | C+ | ||
+10.87% | 98.91B | B- | ||
+2.63% | 98.63B | B | ||
-9.85% | 87.94B | B+ | ||
+17.62% | 74.27B | D+ | ||
+8.49% | 31.02B | B | ||
+20.29% | 29.23B | B | ||
-12.49% | 14.6B | B | ||
+20.70% | 12.73B | A- | ||
+7.82% | 9.96B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBILIFE Stock
- Ratings SBI Life Insurance Company Limited